Table. 1.

Details of patient’s characteristics and comorbidities

Patient characteristic Non-myosteatosis Myosteatosis Total p-value
Sex Female 29 (30.9) 66 (55.0) 95 (44.4) 0.001
Male 65 (69.1) 54 (45.0) 119 (55.6)
Preoperative stenting No 23 (24.5) 29 (24.2) 52 (24.3) > 0.999
Yes 70 (74.5) 90 (75.0) 160 (74.8)
Missing 1 (1.1) 1 (0.8) 2 (0.9)
ASA grade 1 14 (14.9) 6 (5.0) 20 (9.3) 0.019
2 54 (57.4) 66 (55.0) 120 (56.1)
3 16 (17.0) 33 (27.5) 49 (22.9)
Missing 10 (10.6) 15 (12.5) 25 (11.7)
Cardiovascular disease No 76 (80.9) 90 (75.0) 166 (77.6) 0.327
Yes 18 (19.1) 30 (25.0) 48 (22.4)
Respiratory disease No 86 (91.5) 102 (85.0) 188 (87.9) 0.206
Yes 8 (8.5) 18 (15.0) 26 (12.1)
Diabete No 87 (92.6) 114 (95.0) 201 (93.9) 0.567
Yes 7 (7.4) 6 (5.0) 13 (6.1)

Values are presented as number (%).

Ann Hepatobiliary Pancreat Surg 2024;28:494-9 https://doi.org/10.14701/ahbps.23-115
© 2024 Ann Hepatobiliary Pancreat Surg